Birmingham Heart Clinic, PC

Birmingham, Alabama 35235

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Atrial Flutter, CRT-D Cardiac Resynchronization Therapy Defibrillator, Cardiomyopathy, Cardiovascular Disease, Chronic Total Occlusion of Coronary Artery, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Restenosis, Heart Failure

Studies at this site

• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation — Status unconfirmed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early